News 2026
28.09.2026
What role do membrane contact sites play in bacterial pathogenesis and infection?
To explore this question, 24 PIs from across Germany, representing two scientific communities - lipid biology and infection biology - came together at the Centre for Structural Systems Biology CSSB in Hamburg to develop new ideas and shape a joint research concept.
19.09.2026
Lindsay Sonnenkalb receives Isabelle-Olivieri Medal
Dr. Lindsay Sonnenkalb from the Research Center Borstel, Leibniz Lung Center (FZB) has been awarded the 2026 Isabelle-Olivieri Medal for an outstanding publication in the field of translational evolutionary research. The €5,000 award was presented early September during the TransEvo retreat “Evolution by the Lake”.
17.09.2026
Drug-resistant tuberculosis in Ukraine driven by transmission of successful bacterial strains
One of the largest genomic studies of tuberculosis in Ukraine reveals extensive transmission of drug-resistant strains, while resistance to key fluoroquinolones declined substantially between 2019 and 2023.
10.09.2026
Silke Meiners takes on the role of Vice-President of the European Respiratory Society
A role of great responsibility at European level: Prof. Silke Meiners was elected as the new Vice-President of the European Respiratory Society (ERS) this Tuesday. The election took place during this year’s ERS Congress, which was held in Barcelona from 5 to 9 September 2026. With more than 20,000 participants each year, the congress is regarded as the world’s largest gathering of specialists in respiratory medicine and research.
09.09.2026
Building the world's evidence base to tackle drug-resistant tuberculosis
A new international programme, RESPECT-TB, coordinated by the Nuffield Department of Medicine at the University of Oxford in collaboration with the University of the Witwatersrand South Africa and Queen Mary University of London, will unite researchers and national tuberculosis programmes across five high-burden countries to build one of the world's richest evidence resources on drug-resistant tuberculosis (TB).